<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:fil="http://stimcell.com/20260831"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="stme-20260831.xsd" xlink:type="simple"/>
    <context id="D260601_260831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="I260831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I261014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
        </entity>
        <period>
            <instant>2026-10-14</instant>
        </period>
    </context>
    <context id="I260531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D250601_250831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="D260601_260831_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D260601_260831_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D260601_260831_StEqComps-Reserves1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">fil:Reserves1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D260601_260831_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D260601_260831_StEqComps-AccumulatedOtherComprIncome">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="I250531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="I250531_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="I250531_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="I250531_StEqComps-Reserves1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">fil:Reserves1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="I250531_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="I250531_StEqComps-AccumulatedOtherComprIncome">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="D250601_250831_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_StEqComps-Reserves1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">fil:Reserves1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_StEqComps-AccumulatedOtherComprIncome">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="I250831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="I250831_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="I250831_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="I250831_StEqComps-Reserves1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">fil:Reserves1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="I250831_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="I250831_StEqComps-AccumulatedOtherComprIncome">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="I260531_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260531_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260531_StEqComps-Reserves1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">fil:Reserves1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260531_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260531_StEqComps-AccumulatedOtherComprIncome">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260831_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260831_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260831_StEqComps-Reserves1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">fil:Reserves1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260831_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260831_StEqComps-AccumulatedOtherComprIncome">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260831_RelPtyTrn-DueToTheCeo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:DueToTheCeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_RelPtyTrn-DueToTheCeo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:DueToTheCeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260831_RelPtyTrn-DueToCfo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:DueToCfoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_RelPtyTrn-DueToCfo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:DueToCfoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260831_RelPtyTrn-DueToAnEntityControlledByADirectorOfTheCompany">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:DueToAnEntityControlledByADirectorOfTheCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_RelPtyTrn-DueToAnEntityControlledByADirectorOfTheCompany">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:DueToAnEntityControlledByADirectorOfTheCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D260601_260831_RelPtyTrn-ManagementFeesIncurredToACeo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:ManagementFeesIncurredToACeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_RelPtyTrn-ManagementFeesIncurredToACeo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:ManagementFeesIncurredToACeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="D260601_260831_RelPtyTrn-ManagementFeesIncurredToTheCfo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:ManagementFeesIncurredToTheCfoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_RelPtyTrn-ManagementFeesIncurredToTheCfo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:ManagementFeesIncurredToTheCfoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="D260601_260831_RelPtyTrn-ConsultingFeesIncurredToAnEntityControlledByADirectorOfTheCompany">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:ConsultingFeesIncurredToAnEntityControlledByADirectorOfTheCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_RelPtyTrn-ConsultingFeesIncurredToAnEntityControlledByADirectorOfTheCompany">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fil:ConsultingFeesIncurredToAnEntityControlledByADirectorOfTheCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-RelPtyLoansPay">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-RelPtyLoansPay2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyLoansPayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-RelPtyAdvances">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-RelPtyLoansPay">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-RelPtyLoansPay2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyLoansPayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-RelPtyAdvances">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D260601_260831_ShortTermDebtType-LoansToRichardJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToRichardJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-LoansToRichardJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToRichardJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-LoansToRichardJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToRichardJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-LoansToRicjardJeffsAt6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToRicjardJeffsAt6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-LoansToRicjardJeffsAt10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToRicjardJeffsAt10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="D250601_250831_ShortTermDebtType-LoansToRichardJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToRichardJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-LoansToDavidJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToDavidJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-LoansToDavidJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToDavidJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D260601_260831_ShortTermDebtType-AdvancesFromDavidJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:AdvancesFromDavidJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_ShortTermDebtType-AdvancesFromDavidJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:AdvancesFromDavidJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToACompanyDavidJeffsIsADirectorOfMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToACompanyDavidJeffsIsADirectorOfMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D260601_260831_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToACompanyDavidJeffsIsADirectorOfMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToACompanyDavidJeffsIsADirectorOfMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-RelPtyLoanWithMrAmir">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyLoanWithMrAmirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-RelPtyLoanWithMrAmir">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyLoanWithMrAmirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-NotePayToMrAhdoot">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:NotePayablesToMrAhdootMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="D260601_260831_ShortTermDebtType-RelPtyLoanWithMrAmir">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyLoanWithMrAmirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_ShortTermDebtType-RelPtyLoanWithMrAmir">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:RelatedPartyLoanWithMrAmirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-NotePayToMrAhdoot">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:NotePayablesToMrAhdootMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D260601_260831_ShortTermDebtType-NotePayToMrAhdoot">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:NotePayablesToMrAhdootMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_ShortTermDebtType-NotePayToMrAhdoot">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:NotePayablesToMrAhdootMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="I260831_ShortTermDebtType-LoansToSusanJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToSusanJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_ShortTermDebtType-LoansToSusanJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToSusanJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D260601_260831_ShortTermDebtType-LoansToSusanJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToSusanJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D250601_250831_ShortTermDebtType-LoansToSusanJeffs">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToSusanJeffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="I260831_FvByAssetClass-PrepaidExpenses">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">fil:PrepaidExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_FvByAssetClass-PrepaidExpenses">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">fil:PrepaidExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="I260831_FvByAssetClass-RecvAssociatedWithGstCellMedxCanada">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">fil:ReceivablesAssociatedWithGstCellMedxCanadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="I260531_FvByAssetClass-RecvAssociatedWithGstCellMedxCanada">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">fil:ReceivablesAssociatedWithGstCellMedxCanadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D260601_260831_ResearchAndDvlpArrangementContractToPerformForOthersByType-AdmTronics">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fil:AdmTronicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="I260531_ResearchAndDvlpArrangementContractToPerformForOthersByType-ProprietaryMicrocurrentDevice">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fil:ProprietaryMicrocurrentDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="D260601_260831_ResearchAndDvlpArrangementContractToPerformForOthersByType-ProprietaryMicrocurrentDevice">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fil:ProprietaryMicrocurrentDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="D260901_261013_ShortTermDebtType-LoansToRicjardJeffsAt10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToRicjardJeffsAt10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-01</startDate>
            <endDate>2026-10-13</endDate>
        </period>
    </context>
    <context id="D260901_261013_ShortTermDebtType-LoansToMrJeffs102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001493712</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LoansToMrJeffs102Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-01</startDate>
            <endDate>2026-10-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="UsdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="D260601_260831" id="fact1">0001493712</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="D260601_260831" id="fact2">--05-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag contextRef="D260601_260831" id="fact3">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="D260601_260831" id="fact4">2027</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="D260601_260831" id="fact5">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType contextRef="D260601_260831" id="ixv-4775">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="D260601_260831" id="ixv-4776">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="D260601_260831" id="ixv-4777">2026-08-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="D260601_260831" id="ixv-4778">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="D260601_260831" id="ixv-4779">000-54500</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="D260601_260831" id="ixv-4780">StimCell Energetics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="D260601_260831" id="ixv-4781">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="D260601_260831" id="ixv-4782">38-3939625</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="D260601_260831" id="ixv-4783">1130 Pender Street, West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="D260601_260831" id="ixv-4784">Suite 555</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="D260601_260831" id="ixv-4785">Vancouver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="D260601_260831" id="ixv-4786">BC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="D260601_260831" id="ixv-4787">V6E 4A4</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="D260601_260831" id="ixv-4788">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="D260601_260831" id="ixv-4789">238-2692</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="D260601_260831" id="ixv-4790">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="D260601_260831" id="ixv-4791">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="D260601_260831" id="ixv-4792">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="D260601_260831" id="ixv-4793">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="D260601_260831" id="ixv-4794">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="D260601_260831" id="ixv-4795">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="I261014"
      decimals="INF"
      id="ixv-4796"
      unitRef="Shares">21141272</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="I260831"
      decimals="INF"
      id="ixv-4797"
      unitRef="USD">6883</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="I260531"
      decimals="INF"
      id="ixv-4798"
      unitRef="USD">3057</us-gaap:Cash>
    <us-gaap:OtherAssetsCurrent
      contextRef="I260831"
      decimals="INF"
      id="ixv-4799"
      unitRef="USD">54063</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="I260531"
      decimals="INF"
      id="ixv-4800"
      unitRef="USD">78397</us-gaap:OtherAssetsCurrent>
    <us-gaap:Assets
      contextRef="I260831"
      decimals="INF"
      id="ixv-4801"
      unitRef="USD">60946</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="I260531"
      decimals="INF"
      id="ixv-4802"
      unitRef="USD">81454</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="I260831"
      decimals="INF"
      id="ixv-4803"
      unitRef="USD">342016</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="I260531"
      decimals="INF"
      id="ixv-4804"
      unitRef="USD">356302</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="I260831"
      decimals="INF"
      id="ixv-4805"
      unitRef="USD">41183</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="I260531"
      decimals="INF"
      id="ixv-4806"
      unitRef="USD">37674</us-gaap:AccruedLiabilitiesCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260831"
      decimals="INF"
      id="ixv-4807"
      unitRef="USD">684074</fil:DueToRelatedPartyCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260531"
      decimals="INF"
      id="ixv-4808"
      unitRef="USD">665321</fil:DueToRelatedPartyCurrent>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260831"
      decimals="INF"
      id="ixv-4809"
      unitRef="USD">965200</fil:NotesAndAdvancesDueToRelatedParties>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260531"
      decimals="INF"
      id="ixv-4810"
      unitRef="USD">833477</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:Liabilities
      contextRef="I260831"
      decimals="INF"
      id="ixv-4811"
      unitRef="USD">2032473</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="I260531"
      decimals="INF"
      id="ixv-4812"
      unitRef="USD">1892774</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="I260831"
      decimals="INF"
      id="ixv-4813"
      unitRef="UsdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="I260831"
      decimals="INF"
      id="ixv-4814"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="I260831"
      decimals="INF"
      id="ixv-4815"
      unitRef="Shares">21141272</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="I260831"
      decimals="INF"
      id="ixv-4816"
      unitRef="USD">21141</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="I260531"
      decimals="INF"
      id="ixv-4817"
      unitRef="USD">21141</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="I260831"
      decimals="INF"
      id="ixv-4818"
      unitRef="USD">9470616</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="I260531"
      decimals="INF"
      id="ixv-4819"
      unitRef="USD">9470616</us-gaap:AdditionalPaidInCapital>
    <fil:Reserves
      contextRef="I260831"
      decimals="INF"
      id="ixv-4820"
      unitRef="USD">366493</fil:Reserves>
    <fil:Reserves
      contextRef="I260531"
      decimals="INF"
      id="ixv-4821"
      unitRef="USD">366493</fil:Reserves>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="I260831"
      decimals="INF"
      id="ixv-4822"
      unitRef="USD">-11926449</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="I260531"
      decimals="INF"
      id="ixv-4823"
      unitRef="USD">-11756931</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="I260831"
      decimals="INF"
      id="ixv-4824"
      unitRef="USD">96672</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="I260531"
      decimals="INF"
      id="ixv-4825"
      unitRef="USD">87361</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260831"
      decimals="INF"
      id="ixv-4826"
      unitRef="USD">-1971527</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260531"
      decimals="INF"
      id="ixv-4827"
      unitRef="USD">-1811320</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="I260831"
      decimals="INF"
      id="ixv-4828"
      unitRef="USD">60946</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="I260531"
      decimals="INF"
      id="ixv-4829"
      unitRef="USD">81454</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4830"
      unitRef="USD">7500</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4831"
      unitRef="USD">34830</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4832"
      unitRef="USD">-6704</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4833"
      unitRef="USD">1769</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4834"
      unitRef="USD">67296</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4835"
      unitRef="USD">139484</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ManagementFeeExpense
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4836"
      unitRef="USD">22500</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4837"
      unitRef="USD">22500</us-gaap:ManagementFeeExpense>
    <fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4838"
      unitRef="USD">42558</fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease>
    <fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4839"
      unitRef="USD">57309</fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease>
    <us-gaap:OperatingExpenses
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4840"
      unitRef="USD">146558</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4841"
      unitRef="USD">252354</us-gaap:OperatingExpenses>
    <us-gaap:InterestExpense
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4842"
      unitRef="USD">22960</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4843"
      unitRef="USD">13248</us-gaap:InterestExpense>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4844"
      unitRef="USD">-169518</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4845"
      unitRef="USD">-265602</us-gaap:ProfitLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4846"
      unitRef="USD">9311</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4847"
      unitRef="USD">-2061</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4848"
      unitRef="USD">-160207</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4849"
      unitRef="USD">-267663</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4850"
      unitRef="UsdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4851"
      unitRef="UsdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4852"
      unitRef="Shares">21141272</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4853"
      unitRef="Shares">20319261</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="I250531_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4854"
      unitRef="Shares">20141272</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250531_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4855"
      unitRef="USD">20141</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250531_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-4856"
      unitRef="USD">9146591</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250531_StEqComps-Reserves1"
      decimals="INF"
      id="ixv-4857"
      unitRef="USD">366493</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250531_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-4858"
      unitRef="USD">-10861556</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250531_StEqComps-AccumulatedOtherComprIncome"
      decimals="INF"
      id="ixv-4859"
      unitRef="USD">82045</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250531"
      decimals="INF"
      id="ixv-4860"
      unitRef="USD">-1246286</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="D250601_250831_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4861"
      unitRef="Shares">375000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="D250601_250831_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4862"
      unitRef="USD">375</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="D250601_250831_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-4863"
      unitRef="USD">119625</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="D250601_250831_StEqComps-RetainedEarnings"
      decimals="128"
      id="ixv-4864"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="D250601_250831_StEqComps-AccumulatedOtherComprIncome"
      decimals="128"
      id="ixv-4865"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4866"
      unitRef="USD">120000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831_StEqComps-CommonStock"
      decimals="128"
      id="ixv-4867"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831_StEqComps-CommonStock"
      decimals="128"
      id="ixv-4868"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831_StEqComps-AddPaidInCap"
      decimals="128"
      id="ixv-4869"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831_StEqComps-Reserves1"
      decimals="128"
      id="ixv-4870"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-4871"
      unitRef="USD">-265602</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831_StEqComps-AccumulatedOtherComprIncome"
      decimals="128"
      id="ixv-4872"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4873"
      unitRef="USD">-265602</us-gaap:ProfitLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D250601_250831_StEqComps-CommonStock"
      decimals="128"
      id="ixv-4874"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D250601_250831_StEqComps-CommonStock"
      decimals="128"
      id="ixv-4875"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D250601_250831_StEqComps-AddPaidInCap"
      decimals="128"
      id="ixv-4876"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D250601_250831_StEqComps-Reserves1"
      decimals="128"
      id="ixv-4877"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D250601_250831_StEqComps-RetainedEarnings"
      decimals="128"
      id="ixv-4878"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D250601_250831_StEqComps-AccumulatedOtherComprIncome"
      decimals="INF"
      id="ixv-4879"
      unitRef="USD">-2061</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4880"
      unitRef="USD">-2061</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:SharesOutstanding
      contextRef="I250831_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4881"
      unitRef="Shares">20516272</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250831_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4882"
      unitRef="USD">20516</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250831_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-4883"
      unitRef="USD">9266216</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250831_StEqComps-Reserves1"
      decimals="INF"
      id="ixv-4884"
      unitRef="USD">366493</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250831_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-4885"
      unitRef="USD">-11127158</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250831_StEqComps-AccumulatedOtherComprIncome"
      decimals="INF"
      id="ixv-4886"
      unitRef="USD">79984</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I250831"
      decimals="INF"
      id="ixv-4887"
      unitRef="USD">-1393949</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="I260531_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4888"
      unitRef="Shares">21141272</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260531_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4889"
      unitRef="USD">21141</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260531_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-4890"
      unitRef="USD">9470616</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260531_StEqComps-Reserves1"
      decimals="INF"
      id="ixv-4891"
      unitRef="USD">366493</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260531_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-4892"
      unitRef="USD">-11756931</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260531_StEqComps-AccumulatedOtherComprIncome"
      decimals="INF"
      id="ixv-4893"
      unitRef="USD">87361</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260531"
      decimals="INF"
      id="ixv-4894"
      unitRef="USD">-1811320</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831_StEqComps-CommonStock"
      decimals="128"
      id="ixv-4895"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831_StEqComps-CommonStock"
      decimals="128"
      id="ixv-4896"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831_StEqComps-AddPaidInCap"
      decimals="128"
      id="ixv-4897"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831_StEqComps-Reserves1"
      decimals="128"
      id="ixv-4898"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-4899"
      unitRef="USD">-169518</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831_StEqComps-AccumulatedOtherComprIncome"
      decimals="128"
      id="ixv-4900"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4901"
      unitRef="USD">-169518</us-gaap:ProfitLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D260601_260831_StEqComps-CommonStock"
      decimals="128"
      id="ixv-4902"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D260601_260831_StEqComps-CommonStock"
      decimals="128"
      id="ixv-4903"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D260601_260831_StEqComps-AddPaidInCap"
      decimals="128"
      id="ixv-4904"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D260601_260831_StEqComps-Reserves1"
      decimals="128"
      id="ixv-4905"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D260601_260831_StEqComps-RetainedEarnings"
      decimals="128"
      id="ixv-4906"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D260601_260831_StEqComps-AccumulatedOtherComprIncome"
      decimals="INF"
      id="ixv-4907"
      unitRef="USD">9311</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4908"
      unitRef="USD">9311</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:SharesOutstanding
      contextRef="I260831_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4909"
      unitRef="Shares">21141272</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260831_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-4910"
      unitRef="USD">21141</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260831_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-4911"
      unitRef="USD">9470616</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260831_StEqComps-Reserves1"
      decimals="INF"
      id="ixv-4912"
      unitRef="USD">366493</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260831_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-4913"
      unitRef="USD">-11926449</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260831_StEqComps-AccumulatedOtherComprIncome"
      decimals="INF"
      id="ixv-4914"
      unitRef="USD">96672</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="I260831"
      decimals="INF"
      id="ixv-4915"
      unitRef="USD">-1971527</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4916"
      unitRef="USD">-169518</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4917"
      unitRef="USD">-265602</us-gaap:ProfitLoss>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4918"
      unitRef="USD">21366</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4919"
      unitRef="USD">11978</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4920"
      unitRef="USD">1594</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4921"
      unitRef="USD">1270</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNoncashExpense
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4922"
      unitRef="USD">18756</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4923"
      unitRef="USD">120000</us-gaap:OtherNoncashExpense>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4924"
      unitRef="USD">-5377</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4925"
      unitRef="USD">514</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4926"
      unitRef="USD">-5578</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4927"
      unitRef="USD">3307</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4928"
      unitRef="USD">-16644</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4929"
      unitRef="USD">-27482</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4930"
      unitRef="USD">3519</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4931"
      unitRef="USD">11739</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4932"
      unitRef="USD">20977</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4933"
      unitRef="USD">43776</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4934"
      unitRef="USD">-108995</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4935"
      unitRef="USD">-108142</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4936"
      unitRef="USD">112826</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4937"
      unitRef="USD">100000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4938"
      unitRef="USD">112826</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4939"
      unitRef="USD">100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4940"
      unitRef="USD">-5</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4941"
      unitRef="USD">-2</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4942"
      unitRef="USD">3826</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4943"
      unitRef="USD">-8144</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="I260531"
      decimals="INF"
      id="ixv-4944"
      unitRef="USD">3057</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="I250531"
      decimals="INF"
      id="ixv-4945"
      unitRef="USD">14581</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="I260831"
      decimals="INF"
      id="ixv-4946"
      unitRef="USD">6883</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="I250831"
      decimals="INF"
      id="ixv-4947"
      unitRef="USD">6437</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="D260601_260831" id="ixv-1990">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;NOTE 1 - ORGANIZATION AND NATURE OF OPERATIONS&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;StimCell Energetics Inc. (&#x201c;StimCell&#x201d; or the &#x201c;Company&#x201d;) was incorporated under the laws of the State of Nevada. On April 26, 2016, the Company formed a subsidiary, Cell MedX (Canada) Corp. (&#x201c;Cell MedX Canada&#x201d; or the &#x201c;Subsidiary&#x201d;), under the laws of the Province of British Columbia. StimCell is a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;Unaudited Interim Financial Statements&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;The unaudited interim condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). They do not include all the information and footnotes required by GAAP for complete financial statements. Except as disclosed herein, there have been no material changes in the information disclosed in the notes to the consolidated financial statements for the year ended May 31, 2026, included in the Company&#x2019;s Annual Report on Form 10-K, filed with the SEC on August 31, 2026. The interim unaudited condensed consolidated financial statements for the three months ended August 31, 2026, should be read in conjunction with those audited consolidated financial statements included in Form 10-K. In the opinion of management, all adjustments considered necessary for fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the three months ended August 31, 2026, are not necessarily indicative of the results that may be expected for the year ending May 31, 2027.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;Going concern&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. As of August 31, 2026, the Company had cash of $6,883, a working capital deficit of $1,971,527 and an accumulated deficit of $11,926,449. The Company incurred a net loss of $169,518 and used $108,995 in operating activities during the three months ended August 31, 2026. These conditions, together with the Company&#x2019;s dependence on additional financing to meet its obligations, raise substantial doubt about its ability to continue as a going concern within one year after the date these interim consolidated financial statements are issued. Management plans to seek additional debt or equity financing, including financing from related parties. There can be no assurance that sufficient financing will be available. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern. &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;Earnings (Loss) Per Share&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Basic and diluted loss per share are computed in accordance with ASC 260. Basic loss per share is calculated by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution from common share equivalents (e.g., warrants) using the treasury stock method. For the three months ended August 31, 2026, the Company did not have any warrants outstanding; for the comparative period ended August 31, 2025, the effect of such instruments was anti-dilutive, and therefore diluted loss per share was the same as basic loss per share.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;The following table presents the calculation of the loss per share: &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:99%"&gt;&lt;tr&gt;&lt;td style="width:56.04%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:43.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Three months ended&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:11.3pt"&gt;&lt;td style="width:56.04%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.6%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.1%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:56.04%;border-top:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Net loss attributable to common shareholders&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.8%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.8%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(169,518)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.34%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.76%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(265,602)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:56.04%;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Weighted-average common shares outstanding&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.8%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.8%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;21,141,272&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.34%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.76%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;20,319,261&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:56.04%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Loss per common share (basic and diluted)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.8%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.8%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(0.01)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.34%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.76%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(0.01)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:Cash
      contextRef="I260831"
      decimals="INF"
      id="ixv-4948"
      unitRef="USD">6883</us-gaap:Cash>
    <fil:WorkingCapitalDeficit
      contextRef="I260831"
      decimals="INF"
      id="ixv-4949"
      unitRef="USD">1971527</fil:WorkingCapitalDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="I260831"
      decimals="INF"
      id="ixv-4950"
      unitRef="USD">-11926449</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4951"
      unitRef="USD">-169518</us-gaap:ProfitLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4952"
      unitRef="USD">-108995</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="D260601_260831" id="ixv-2004">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;Earnings (Loss) Per Share&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Basic and diluted loss per share are computed in accordance with ASC 260. Basic loss per share is calculated by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution from common share equivalents (e.g., warrants) using the treasury stock method. For the three months ended August 31, 2026, the Company did not have any warrants outstanding; for the comparative period ended August 31, 2025, the effect of such instruments was anti-dilutive, and therefore diluted loss per share was the same as basic loss per share.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;The following table presents the calculation of the loss per share: &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:99%"&gt;&lt;tr&gt;&lt;td style="width:56.04%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:43.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Three months ended&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:11.3pt"&gt;&lt;td style="width:56.04%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.6%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.1%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:56.04%;border-top:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Net loss attributable to common shareholders&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.8%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.8%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(169,518)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.34%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.76%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(265,602)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:56.04%;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Weighted-average common shares outstanding&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.8%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.8%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;21,141,272&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.34%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.76%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;20,319,261&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:56.04%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Loss per common share (basic and diluted)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.8%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.8%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(0.01)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.34%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.76%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(0.01)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="D260601_260831" id="ixv-2011">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:99%"&gt;&lt;tr&gt;&lt;td style="width:56.04%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:43.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Three months ended&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:11.3pt"&gt;&lt;td style="width:56.04%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.6%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.1%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:56.04%;border-top:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Net loss attributable to common shareholders&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.8%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.8%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(169,518)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.34%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.76%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(265,602)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:56.04%;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Weighted-average common shares outstanding&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.8%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.8%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;21,141,272&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.34%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.76%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;20,319,261&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:56.04%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Loss per common share (basic and diluted)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.8%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.8%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(0.01)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.34%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:16.76%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;(0.01)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4953"
      unitRef="USD">-169518</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4954"
      unitRef="USD">-265602</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4955"
      unitRef="Shares">21141272</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4956"
      unitRef="Shares">20319261</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4957"
      unitRef="UsdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4958"
      unitRef="UsdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="D260601_260831" id="ixv-2078">&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;NOTE 2 - RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Amounts due to related parties, other than advances and notes payable to related parties (Note 3) at August 31, 2026, and at May 31, 2026:&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:103.74%"&gt;&lt;tr&gt;&lt;td style="width:62.08%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="width:19.74%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;August 31, 2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.22%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:14.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;May 31, 2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:62.08%;border-top:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Due to the Chief Executive Officer (&#x201c;CEO&#x201d;) and President&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:4.3%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:15.44%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;276,733&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.22%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:11.7%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;250,019&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:62.08%" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Due to the Chief Financial Officer (&#x201c;CFO&#x201d;)&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:4.3%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:15.44%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;6,754&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.22%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:11.7%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;11,760&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:62.08%" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Due to an entity controlled by a director of the Company&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:4.3%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:15.44%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;400,587&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.22%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:11.7%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;403,542&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:62.08%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Due to related parties&lt;span style="vertical-align:super"&gt;(1)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:4.3%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:15.44%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;684,074&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.22%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:11.7%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;665,321&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;margin-left:36pt;text-align:justify"&gt;&lt;kbd style="position:absolute;font:10pt Times New Roman;margin-left:-36pt"&gt;(1)&lt;/kbd&gt;The amounts due to related parties are unsecured, due on demand and bear no interest.&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;During the three months ended August 31, 2026 and 2025, the Company had the following transactions with related parties:&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:104.4%"&gt;&lt;tr&gt;&lt;td style="width:66.94%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="width:15.48%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.42%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:15.16%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:66.94%;border-top:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Management fees incurred to the CEO and President&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.28%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:12.2%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;22,500&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:2.42%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.28%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:11.88%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;22,500&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:66.94%" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Consulting fees incurred to the CFO&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.28%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.2%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;7,500&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.42%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.28%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:11.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;7,500&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:66.94%;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Consulting fees incurred to an entity controlled by a director of the Company&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.28%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:12.2%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:2.42%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.28%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:11.88%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;27,330&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:66.94%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Total management and consulting fees with related parties&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.28%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.2%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;30,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.42%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.28%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:11.88%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;57,330&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="D260601_260831" id="ixv-2083">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:103.74%"&gt;&lt;tr&gt;&lt;td style="width:62.08%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="width:19.74%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;August 31, 2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.22%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:14.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;May 31, 2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:62.08%;border-top:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Due to the Chief Executive Officer (&#x201c;CEO&#x201d;) and President&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:4.3%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:15.44%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;276,733&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.22%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:11.7%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;250,019&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:62.08%" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Due to the Chief Financial Officer (&#x201c;CFO&#x201d;)&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:4.3%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:15.44%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;6,754&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.22%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:11.7%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;11,760&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:62.08%" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Due to an entity controlled by a director of the Company&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:4.3%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:15.44%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;400,587&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.22%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:11.7%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;403,542&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:62.08%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Due to related parties&lt;span style="vertical-align:super"&gt;(1)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:4.3%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:15.44%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;684,074&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.22%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:11.7%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;665,321&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260831_RelPtyTrn-DueToTheCeo"
      decimals="INF"
      id="ixv-4959"
      unitRef="USD">276733</fil:DueToRelatedPartyCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260531_RelPtyTrn-DueToTheCeo"
      decimals="INF"
      id="ixv-4960"
      unitRef="USD">250019</fil:DueToRelatedPartyCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260831_RelPtyTrn-DueToCfo"
      decimals="INF"
      id="ixv-4961"
      unitRef="USD">6754</fil:DueToRelatedPartyCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260531_RelPtyTrn-DueToCfo"
      decimals="INF"
      id="ixv-4962"
      unitRef="USD">11760</fil:DueToRelatedPartyCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260831_RelPtyTrn-DueToAnEntityControlledByADirectorOfTheCompany"
      decimals="INF"
      id="ixv-4963"
      unitRef="USD">400587</fil:DueToRelatedPartyCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260531_RelPtyTrn-DueToAnEntityControlledByADirectorOfTheCompany"
      decimals="INF"
      id="ixv-4964"
      unitRef="USD">403542</fil:DueToRelatedPartyCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260831"
      decimals="INF"
      id="ixv-4965"
      unitRef="USD">684074</fil:DueToRelatedPartyCurrent>
    <fil:DueToRelatedPartyCurrent
      contextRef="I260531"
      decimals="INF"
      id="ixv-4966"
      unitRef="USD">665321</fil:DueToRelatedPartyCurrent>
    <fil:ScheduleOfTransactionsWithRelatedPartiesTextBlock contextRef="D260601_260831" id="ixv-2153">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:104.4%"&gt;&lt;tr&gt;&lt;td style="width:66.94%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="width:15.48%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.42%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:15.16%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:66.94%;border-top:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Management fees incurred to the CEO and President&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.28%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:12.2%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;22,500&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:2.42%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.28%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:11.88%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;22,500&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:66.94%" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Consulting fees incurred to the CFO&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.28%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.2%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;7,500&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.42%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.28%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:11.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;7,500&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:66.94%;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Consulting fees incurred to an entity controlled by a director of the Company&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.28%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:12.2%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:2.42%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:3.28%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:11.88%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;27,330&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:66.94%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Total management and consulting fees with related parties&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.28%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.2%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;30,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.42%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.28%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:11.88%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;57,330&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</fil:ScheduleOfTransactionsWithRelatedPartiesTextBlock>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="D260601_260831_RelPtyTrn-ManagementFeesIncurredToACeo"
      decimals="INF"
      id="ixv-4967"
      unitRef="USD">22500</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="D250601_250831_RelPtyTrn-ManagementFeesIncurredToACeo"
      decimals="INF"
      id="ixv-4968"
      unitRef="USD">22500</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="D260601_260831_RelPtyTrn-ManagementFeesIncurredToTheCfo"
      decimals="INF"
      id="ixv-4969"
      unitRef="USD">7500</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="D250601_250831_RelPtyTrn-ManagementFeesIncurredToTheCfo"
      decimals="INF"
      id="ixv-4970"
      unitRef="USD">7500</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="D260601_260831_RelPtyTrn-ConsultingFeesIncurredToAnEntityControlledByADirectorOfTheCompany"
      decimals="128"
      id="ixv-4971"
      unitRef="USD">0</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="D250601_250831_RelPtyTrn-ConsultingFeesIncurredToAnEntityControlledByADirectorOfTheCompany"
      decimals="INF"
      id="ixv-4972"
      unitRef="USD">27330</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-4973"
      unitRef="USD">30000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-4974"
      unitRef="USD">57330</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:DebtDisclosureTextBlock contextRef="D260601_260831" id="ixv-2223">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;NOTE 3 - NOTES AND ADVANCES DUE TO RELATED PARTIES&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;The tables below summarize the notes and advances due and payable to related parties as at August 31, 2026 and May 31, 2026:&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:99%"&gt;&lt;tr&gt;&lt;td colspan="8" style="width:462.95pt;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;As at August 31, 2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="2" style="width:70.9pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Principal&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Outstanding&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:62.15pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Interest Rate&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;per Annum&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:162.55pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:80.45pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Accrued&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Interest&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:87.25pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Total Book&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Value&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:17.6pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:53.3pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;78,464&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:62.15pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;6%&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:162.55pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Related party notes payable &lt;span style="vertical-align:super"&gt;(1)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:24.85pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:55.6pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;27,596&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:24.85pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="background-color:#DBE5F1;width:62.4pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;106,060&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:17.6pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:53.3pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;723,085&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:62.15pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;10%&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:162.55pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Related party notes payable &lt;span style="vertical-align:super"&gt;(1)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.85pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:55.6pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;125,237&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.85pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:62.4pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;848,322&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:17.6pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:53.3pt;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;10,818&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:62.15pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;0%&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:162.55pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Advances&lt;span style="vertical-align:super"&gt;(2)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:24.85pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:55.6pt;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:24.85pt;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="background-color:#DBE5F1;width:62.4pt;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;10,818&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:17.6pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:53.3pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;812,367&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:62.15pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:162.55pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.85pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:55.6pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;152,833&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.85pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:62.4pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;965,200&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="8" style="width:462.95pt;border-top:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="8" style="width:462.95pt;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;As at May 31, 2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="2" style="width:70.9pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Principal&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Outstanding&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:62.15pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Interest Rate&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;per Annum&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:162.55pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:80.45pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Accrued&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Interest&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:87.25pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Total Book&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;Value&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:17.6pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:53.3pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;78,729&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:62.15pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;6%&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:162.55pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Related party notes payable &lt;span style="vertical-align:super"&gt;(1)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:24.85pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:55.6pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;26,090&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:24.85pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="background-color:#DBE5F1;width:62.4pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;104,819&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:17.6pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:53.3pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;612,335&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:62.15pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;10%&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:162.55pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Related party notes payable &lt;span style="vertical-align:super"&gt;(1)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.85pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:55.6pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;105,452&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.85pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:62.4pt" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;717,787&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#DBE5F1;width:17.6pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:53.3pt;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;10,871&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:62.15pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;0%&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:162.55pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Advances&lt;span style="vertical-align:super"&gt;(2)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:24.85pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:55.6pt;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#DBE5F1;width:24.85pt;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="background-color:#DBE5F1;width:62.4pt;border-bottom:0.5pt solid #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;10,871&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:17.6pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:53.3pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;701,935&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:62.15pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:162.55pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.85pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:55.6pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;131,542&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.85pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:62.4pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;833,477&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;(1) Related Party Notes Payable&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026, the Company owed a total of $106,060 under 6% notes payable due to related parties (May 31, 2026 - $104,819), of which $27,596 was associated with interest accrued on the principal balances owed under the notes payable (May 31, 2026 - $26,090).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026, the Company owed a total of $848,322 under 10% notes payable due to related parties (May 31, 2026 - $717,787), of which $125,237 was associated with interest accrued on the principal balances owed under the notes payable (May 31, 2026 - $105,452).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;&lt;i&gt;Notes payable with Mr. Richard Jeffs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;During the three months ended August 31, 2026, the Company borrowed $50,000 from Mr. Richard Jeffs, a significant shareholder of the Company and the father of the Company&#x2019;s CEO and President, Mr. David Jeffs, under an unsecured credit line, which allows the Company to draw up to $350,000 (as amended on July 16, 2026) at 10% per annum, &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;payable on demand, and a further $62,826 (CAD$85,000) under an unsecured credit line, which allows the Company to draw up to CAD$250,000 at 10% per annum, compounded monthly and payable on demand.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026, the Company owed a total of $436,675 (May 31, 2026 - $316,937) to Mr. Richard Jeffs. A total of $71,323 (including accrued interest of $17,859) was borrowed under unsecured notes payable, which accrue interest at a rate of 6% per annum, compounded monthly, and are due on demand. The remaining carrying amount of $365,352 related to advances under the unsecured credit lines and accrued interest. The credit lines permit the Company to draw up to CAD$250,000 and up to US$350,000 at 10% per annum, compounded monthly and payable on demand.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;During the three months ended August 31, 2026, the Company recorded $8,900 in interest on the notes payable and the funds borrowed under the credit lines with Mr. Richard Jeffs (August 31, 2025 - $3,034).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;&lt;i&gt;Notes payable with Mr. David Jeffs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As of August 31, 2026, the Company owed a total of $53,852 under loan agreements with Mr. David Jeffs, the Company&#x2019;s CEO, director, and a significant shareholder (May 31, 2026 - $52,570). The loans are unsecured and carry a 10% annual interest rate, compounded monthly. A $30,000 note payable included in the total due was payable on April 24, 2023, and, as of the date of these condensed consolidated financial statements, is in default. The remaining notes payable, totaling $7,933, are payable on demand. During the three months ended August 31, 2026, the Company recorded $1,332 in interest on the principal (August 31, 2025 - $1,211).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As of August 31, 2026, the Company owed a total of $34,737 under a loan agreement with a company of which Mr. David Jeffs is a director (May 31, 2026 - $34,217). The loan bears interest at 6% per annum compounded monthly, is unsecured, and is payable on demand. During the three months ended August 31, 2026, the Company recorded $520 in interest on the principal (August 31, 2025 - $490).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;&lt;i&gt;Notes payable with Mr. Amir Vahabzadeh&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026, the Company owed a total of $209,903 under loan agreements with Mr. Vahabzadeh, a director and a significant shareholder (May 31, 2026 - $204,700). The loans are unsecured and carry a 10% annual interest rate, compounded monthly. A $30,000 note payable included in the total due was payable on April 24, 2023, and, as of the date of these condensed consolidated financial statements, is in default. The remaining notes payable, totaling $130,000, are payable on demand. During the three months ended August 31, 2026, the Company recorded $5,203 in interest on the principal (August 31, 2025 - $4,710).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;&lt;i&gt;Notes payable with a significant shareholder&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026, the Company owed $82,417 (May 31, 2026 - $80,374) under unsecured notes payable with the Company&#x2019;s significant shareholder (&#x201c;Mr. Ahdoot&#x201d;). The loans are unsecured, carry a 10% annual interest rate compounded monthly, and are payable on demand. During the three months ended August 31, 2026, the Company recorded $2,043 in interest on the principal (August 31, 2025 - $1,849).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;&lt;i&gt;Notes payable with Mrs. Susan Jeffs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026, the Company owed $136,798 (May 31, 2026 - $133,808) under unsecured credit lines with Mrs. Susan Jeffs, mother of Mr. David Jeffs. The terms of the credit lines allow the Company to draw up to $100,000 and up to CAD$200,000 at 10% per annum compounded monthly, payable on demand. During the three months ended August 31, 2026, the Company recorded $3,368 in interest on the principal (August 31, 2025 - $684).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;(2) Advances Payable&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026, the Company owed a total of $10,818 (May 31, 2026 - $10,871) for an advance the Company received in its fiscal 2020 year from an entity controlled by a director of the Company and Mr. Richard Jeffs. The advance is non-interest-bearing, unsecured, and payable on demand.&lt;/p&gt;
</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LoansPayable
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-4975"
      unitRef="USD">78464</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-4976"
      unitRef="Pure">0.06</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestPayableCurrent
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-4977"
      unitRef="USD">27596</us-gaap:InterestPayableCurrent>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-4978"
      unitRef="USD">106060</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:LoansPayable
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-4979"
      unitRef="USD">723085</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-4980"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestPayableCurrent
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-4981"
      unitRef="USD">125237</us-gaap:InterestPayableCurrent>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-4982"
      unitRef="USD">848322</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:LoansPayable
      contextRef="I260831_ShortTermDebtType-RelPtyAdvances"
      decimals="INF"
      id="ixv-4983"
      unitRef="USD">10818</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="I260831_ShortTermDebtType-RelPtyAdvances"
      decimals="INF"
      id="ixv-4984"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260831_ShortTermDebtType-RelPtyAdvances"
      decimals="INF"
      id="ixv-4985"
      unitRef="USD">10818</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:LoansPayable
      contextRef="I260831"
      decimals="INF"
      id="ixv-4986"
      unitRef="USD">812367</us-gaap:LoansPayable>
    <us-gaap:InterestPayableCurrent
      contextRef="I260831"
      decimals="INF"
      id="ixv-4987"
      unitRef="USD">152833</us-gaap:InterestPayableCurrent>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260831"
      decimals="INF"
      id="ixv-4988"
      unitRef="USD">965200</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:LoansPayable
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-4989"
      unitRef="USD">78729</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-4990"
      unitRef="Pure">0.06</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestPayableCurrent
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-4991"
      unitRef="USD">26090</us-gaap:InterestPayableCurrent>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-4992"
      unitRef="USD">104819</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:LoansPayable
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-4993"
      unitRef="USD">612335</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-4994"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestPayableCurrent
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-4995"
      unitRef="USD">105452</us-gaap:InterestPayableCurrent>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-4996"
      unitRef="USD">717787</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:LoansPayable
      contextRef="I260531_ShortTermDebtType-RelPtyAdvances"
      decimals="INF"
      id="ixv-4997"
      unitRef="USD">10871</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="I260531_ShortTermDebtType-RelPtyAdvances"
      decimals="INF"
      id="ixv-4998"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260531_ShortTermDebtType-RelPtyAdvances"
      decimals="INF"
      id="ixv-4999"
      unitRef="USD">10871</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:LoansPayable
      contextRef="I260531"
      decimals="INF"
      id="ixv-5000"
      unitRef="USD">701935</us-gaap:LoansPayable>
    <us-gaap:InterestPayableCurrent
      contextRef="I260531"
      decimals="INF"
      id="ixv-5001"
      unitRef="USD">131542</us-gaap:InterestPayableCurrent>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260531"
      decimals="INF"
      id="ixv-5002"
      unitRef="USD">833477</fil:NotesAndAdvancesDueToRelatedParties>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-5003"
      unitRef="USD">106060</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-5004"
      unitRef="Pure">0.06</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-5005"
      unitRef="USD">104819</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:InterestPayableCurrent
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-5006"
      unitRef="USD">27596</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay"
      decimals="INF"
      id="ixv-5007"
      unitRef="USD">26090</us-gaap:InterestPayableCurrent>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-5008"
      unitRef="USD">848322</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-5009"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <fil:NotesAndAdvancesDueToRelatedParties
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-5010"
      unitRef="USD">717787</fil:NotesAndAdvancesDueToRelatedParties>
    <us-gaap:InterestPayableCurrent
      contextRef="I260831_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-5011"
      unitRef="USD">125237</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="I260531_ShortTermDebtType-RelPtyLoansPay2"
      decimals="INF"
      id="ixv-5012"
      unitRef="USD">105452</us-gaap:InterestPayableCurrent>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="D260601_260831_ShortTermDebtType-LoansToRichardJeffs"
      decimals="INF"
      id="ixv-5013"
      unitRef="USD">50000</us-gaap:ProceedsFromRelatedPartyDebt>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260831_ShortTermDebtType-LoansToRichardJeffs"
      decimals="INF"
      id="ixv-5014"
      unitRef="USD">436675</fil:RelatedPartyPayablesLoans>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260531_ShortTermDebtType-LoansToRichardJeffs"
      decimals="INF"
      id="ixv-5015"
      unitRef="USD">316937</fil:RelatedPartyPayablesLoans>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260831_ShortTermDebtType-LoansToRicjardJeffsAt6"
      decimals="INF"
      id="ixv-5016"
      unitRef="USD">71323</fil:RelatedPartyPayablesLoans>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="I260831_ShortTermDebtType-LoansToRicjardJeffsAt6"
      decimals="INF"
      id="ixv-5017"
      unitRef="Pure">0.06</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260831_ShortTermDebtType-LoansToRicjardJeffsAt10"
      decimals="INF"
      id="ixv-5018"
      unitRef="USD">365352</fil:RelatedPartyPayablesLoans>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="I260831_ShortTermDebtType-LoansToRicjardJeffsAt10"
      decimals="INF"
      id="ixv-5019"
      unitRef="Pure">0.10</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:InterestExpense
      contextRef="D260601_260831_ShortTermDebtType-LoansToRichardJeffs"
      decimals="INF"
      id="ixv-5020"
      unitRef="USD">8900</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="D250601_250831_ShortTermDebtType-LoansToRichardJeffs"
      decimals="INF"
      id="ixv-5021"
      unitRef="USD">3034</us-gaap:InterestExpense>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260831_ShortTermDebtType-LoansToDavidJeffs"
      decimals="INF"
      id="ixv-5022"
      unitRef="USD">53852</fil:RelatedPartyPayablesLoans>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260531_ShortTermDebtType-LoansToDavidJeffs"
      decimals="INF"
      id="ixv-5023"
      unitRef="USD">52570</fil:RelatedPartyPayablesLoans>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="I260831_ShortTermDebtType-LoansToDavidJeffs"
      decimals="INF"
      id="ixv-5024"
      unitRef="Pure">0.10</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:InterestExpense
      contextRef="D260601_260831_ShortTermDebtType-AdvancesFromDavidJeffs"
      decimals="INF"
      id="ixv-5025"
      unitRef="USD">1332</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="D250601_250831_ShortTermDebtType-AdvancesFromDavidJeffs"
      decimals="INF"
      id="ixv-5026"
      unitRef="USD">1211</us-gaap:InterestExpense>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260831_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf"
      decimals="INF"
      id="ixv-5027"
      unitRef="USD">34737</fil:RelatedPartyPayablesLoans>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260531_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf"
      decimals="INF"
      id="ixv-5028"
      unitRef="USD">34217</fil:RelatedPartyPayablesLoans>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="I260831_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf"
      decimals="INF"
      id="ixv-5029"
      unitRef="Pure">0.06</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:InterestExpense
      contextRef="D260601_260831_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf"
      decimals="INF"
      id="ixv-5030"
      unitRef="USD">520</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="D250601_250831_ShortTermDebtType-LoansToACompanyDavidJeffsIsADirectorOf"
      decimals="INF"
      id="ixv-5031"
      unitRef="USD">490</us-gaap:InterestExpense>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260831_ShortTermDebtType-RelPtyLoanWithMrAmir"
      decimals="INF"
      id="ixv-5032"
      unitRef="USD">209903</fil:RelatedPartyPayablesLoans>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260531_ShortTermDebtType-RelPtyLoanWithMrAmir"
      decimals="INF"
      id="ixv-5033"
      unitRef="USD">204700</fil:RelatedPartyPayablesLoans>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="I260831_ShortTermDebtType-NotePayToMrAhdoot"
      decimals="INF"
      id="ixv-5034"
      unitRef="Pure">0.10</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:InterestExpense
      contextRef="D260601_260831_ShortTermDebtType-RelPtyLoanWithMrAmir"
      decimals="INF"
      id="ixv-5035"
      unitRef="USD">5203</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="D250601_250831_ShortTermDebtType-RelPtyLoanWithMrAmir"
      decimals="INF"
      id="ixv-5036"
      unitRef="USD">4710</us-gaap:InterestExpense>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260831_ShortTermDebtType-NotePayToMrAhdoot"
      decimals="INF"
      id="ixv-5037"
      unitRef="USD">82417</fil:RelatedPartyPayablesLoans>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260531_ShortTermDebtType-NotePayToMrAhdoot"
      decimals="INF"
      id="ixv-5038"
      unitRef="USD">80374</fil:RelatedPartyPayablesLoans>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="I260831_ShortTermDebtType-NotePayToMrAhdoot"
      decimals="INF"
      id="ixv-5039"
      unitRef="Pure">0.10</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:InterestExpense
      contextRef="D260601_260831_ShortTermDebtType-NotePayToMrAhdoot"
      decimals="INF"
      id="ixv-5040"
      unitRef="USD">2043</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="D250601_250831_ShortTermDebtType-NotePayToMrAhdoot"
      decimals="INF"
      id="ixv-5041"
      unitRef="USD">1849</us-gaap:InterestExpense>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260831_ShortTermDebtType-LoansToSusanJeffs"
      decimals="INF"
      id="ixv-5042"
      unitRef="USD">136798</fil:RelatedPartyPayablesLoans>
    <fil:RelatedPartyPayablesLoans
      contextRef="I260531_ShortTermDebtType-LoansToSusanJeffs"
      decimals="INF"
      id="ixv-5043"
      unitRef="USD">133808</fil:RelatedPartyPayablesLoans>
    <us-gaap:InterestExpense
      contextRef="D260601_260831_ShortTermDebtType-LoansToSusanJeffs"
      decimals="INF"
      id="ixv-5044"
      unitRef="USD">3368</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="D250601_250831_ShortTermDebtType-LoansToSusanJeffs"
      decimals="INF"
      id="ixv-5045"
      unitRef="USD">684</us-gaap:InterestExpense>
    <fil:NotesPayableRelatedPartiesOther
      contextRef="I260831"
      decimals="INF"
      id="ixv-5046"
      unitRef="USD">10818</fil:NotesPayableRelatedPartiesOther>
    <fil:NotesPayableRelatedPartiesOther
      contextRef="I260531"
      decimals="INF"
      id="ixv-5047"
      unitRef="USD">10871</fil:NotesPayableRelatedPartiesOther>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="D260601_260831" id="ixv-2473">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;NOTE 4 - OTHER CURRENT ASSETS&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026, other current assets consisted of $54,028 in prepaid expenses (May 31, 2026 - $78,368) and $35 in receivables associated with GST Cell MedX Canada paid on taxable supplies (May 31, 2026 - $29).&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;During the three months ended August 31, 2026, the Company recognized $18,756 of investor-relations expense, originally prepaid through a prior-year issuance of common shares, through amortization of prepaid services.&lt;/p&gt;
</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:OtherAssetsCurrent
      contextRef="I260831_FvByAssetClass-PrepaidExpenses"
      decimals="INF"
      id="ixv-5048"
      unitRef="USD">54028</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="I260531_FvByAssetClass-PrepaidExpenses"
      decimals="INF"
      id="ixv-5049"
      unitRef="USD">78368</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="I260831_FvByAssetClass-RecvAssociatedWithGstCellMedxCanada"
      decimals="INF"
      id="ixv-5050"
      unitRef="USD">35</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="I260531_FvByAssetClass-RecvAssociatedWithGstCellMedxCanada"
      decimals="INF"
      id="ixv-5051"
      unitRef="USD">29</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherNoncashExpense
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-5052"
      unitRef="USD">18756</us-gaap:OtherNoncashExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="D260601_260831" id="ixv-2481">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;NOTE 5 - SHARE CAPITAL&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;During the three months ended August 31, 2026, the Company did not have any transactions resulting in issuance of shares.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026 and May 31, 2026, the Company did not have any outstanding share purchase options.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;As at August 31, 2026 and May 31, 2026, the Company did not have any outstanding warrants.&lt;/p&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="D260601_260831" id="ixv-2497">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;NOTE 6 - RESEARCH AND DEVELOPMENT&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;In February 2025, the Company engaged ADM Tronics Unlimited, Inc (&#x201c;ADM Tronics&#x201d;) to redesign its eBalance&#xae; microcurrent device. The Company expected the project to take approximately 22 to 34 weeks and to cost between $62,500 and $127,000. As of August 31, 2026, the Company and ADM Tronics continue working on the project at a regular hourly fee.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;During the three months ended August 31, 2026, the Company incurred a total of $42,558 for this project, of which $35,993 was incurred under the agreement with ADM Tronics (August 31, 2025 - $57,309). As of August 31, 2026, the Company had incurred a total of $294,590 with ADM Tronics since February 2025.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;On December 1, 2025, the Company entered into a service agreement to conduct a study examining the effects of the eBalance&#xae; microcurrent device. The study was expected to last three months and cost approximately $27,100. During the year ended May 31, 2026, the Company made an initial payment of $13,546, which was recorded as a prepaid expense as the study was postponed until the new eBalance&#xae; microcurrent devices were ready for testing. The study began in August 2026, and the Company recognized $1,129 for the three-month period ended August 31, 2026.&lt;/p&gt;
</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareActivityDescription contextRef="D260601_260831" id="ixv-5053">The Company expected the project to take approximately 22 to 34 weeks and to cost between $62,500 and $127,000</us-gaap:ResearchDevelopmentAndComputerSoftwareActivityDescription>
    <fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease
      contextRef="D260601_260831"
      decimals="INF"
      id="ixv-5054"
      unitRef="USD">42558</fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease>
    <fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease
      contextRef="D260601_260831_ResearchAndDvlpArrangementContractToPerformForOthersByType-AdmTronics"
      decimals="INF"
      id="ixv-5055"
      unitRef="USD">35993</fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease>
    <fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease
      contextRef="D250601_250831"
      decimals="INF"
      id="ixv-5056"
      unitRef="USD">57309</fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease>
    <fil:AccumulatedRDProjectExpense
      contextRef="I260831"
      decimals="INF"
      id="ixv-5057"
      unitRef="USD">294590</fil:AccumulatedRDProjectExpense>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="I260531_ResearchAndDvlpArrangementContractToPerformForOthersByType-ProprietaryMicrocurrentDevice"
      decimals="INF"
      id="ixv-5058"
      unitRef="USD">13546</us-gaap:PrepaidExpenseCurrent>
    <fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease
      contextRef="D260601_260831_ResearchAndDvlpArrangementContractToPerformForOthersByType-ProprietaryMicrocurrentDevice"
      decimals="INF"
      id="ixv-5059"
      unitRef="USD">1129</fil:ResearchAndDevelopmentExpenseIncreaseAndDecrease>
    <us-gaap:SubsequentEventsTextBlock contextRef="D260601_260831" id="ixv-2507">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&lt;b&gt;NOTE 7 - SUBSEQUENT EVENT&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Subsequent to August 31, 2026, the Company borrowed $50,000 from Mr. Richard Jeffs under an unsecured credit line, which allows the Company to draw up to $350,000 at 10% per annum, payable on demand, and a further $35,112 (CAD$50,000) under an unsecured credit line, which allows the Company to draw up to CAD$250,000 at 10% per annum, compounded monthly and payable on demand.&lt;/p&gt;
</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="D260901_261013_ShortTermDebtType-LoansToRicjardJeffsAt10"
      decimals="INF"
      id="ixv-5060"
      unitRef="USD">50000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="D260901_261013_ShortTermDebtType-LoansToMrJeffs102"
      decimals="INF"
      id="ixv-5061"
      unitRef="USD">35112</us-gaap:ProceedsFromRelatedPartyDebt>
</xbrl>
